Therapeutic strategies after coronary stenting in chronically anticoagulated patients: The MUSICA study

Heart

Volumn 95, Issue 18, 2009, Pages 1483-1488

  Sambola, A ^a   Ferreira Gonzalez I ^a,k   Angel, J ^a   Alfonso, F ^b   Maristany, J ^c   Rodriguez O ^d   Bueno, H ^e   Lopez Minguez J R ^f   Zueco, J ^g   Fernandez Aviles F ^e   San Roman A ^h   Prendergast, B ⁱ   Mainar, V ^j   Garcia Dorado D ^a   Tornos, P ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f HOSPITAL INFANTA CRISTINA   (Spain)

^g HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^h Department of Cardiac Surgery   (Spain)

ⁱ JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^j Hospital Universitario de Alicante   (Spain)

^k CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; BLEEDING; CARDIOTOXICITY; CONTROLLED STUDY; CORONARY STENT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPAIN; STENT THROMBOSIS; STROKE; TEACHING HOSPITAL; THROMBOEMBOLISM; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CHRONIC DISEASE; CORONARY DISEASE; DISEASE-FREE SURVIVAL; DRUG THERAPY, COMBINATION; FEMALE; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; REGISTRIES; STENTS; THROMBOEMBOLISM; TICLOPIDINE; TREATMENT OUTCOME; WARFARIN;

EID: 69549106563     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.167064     Document Type: Article

References (21)

1. Mehta SR, Yusuf S, Peters RJ, et al. Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-533
2. Leon M, Baim D, Popma J, et al. Randomized trial comparing three drug regimens to prevent thrombosis following elective coronary stenting. N Engl J Med 1998;339:1665-1671
3. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary stents. N Engl J Med 1996;334:1084-1089 (Pubitemid 26120185)
4. Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation versus Aspirin and Ticlopidine (FANTASTIC) study. Circulation 1998;98:1597-1603
5. May A, Geisler T, Gawaz M. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edge sword between thrombosis and bleeding. Thromb Haemost 2008;99:487-493
6. Orford JL, Fasseas P, Melby S, et al. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J 2004;147:463-467 (Pubitemid 38880866)
7. Karjalainen PP, Porela P, Ylitalo A, et al. Safety and efficacy of combined antiplatelet warfarin therapy after coronary stenting. Eur Heart J 2007;28:726-732 (Pubitemid 46439228)
8. Manzano-Fernández S, Pastor FJ, Marín F, et al. Increased major bleeding complication related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest 2008;134:559-567
9. Khurram Z, Chou E, Minutello R, et al. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with significant risk of bleeding. J Invasive Cardiol 2006;18:162-164 (Pubitemid 44576090)
10. Mattichak SJ, Reed PS, Galllagher MJ, et al. Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction. J Interv Cardiol 2005;18:163-166 (Pubitemid 40942726)
11. De Feyter P, Van den Brand M, Laarman G, et al. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty: frequency, prediction, clinical course, management and follow-up. Circulation 1991;83:927-936
12. Allen J, Sylvia B, Bridges J, et al. Stent thrombosis alters successful sirolimuseluting stent implantation. Circulation 2004;109:1930-1932 (Pubitemid 38544480)
13. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. Task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-847
14. King S III, Smith S, Hirshfeld J, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines: 2007 writing group to review new evidence and update the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention, writing on behalf of guideline update the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention, writing on behalf of the 2005 writing committee. Circulation 2008;117:261-295
15. Gage BF, Waterman AD, Shennon W, et al. Validation of clinical classification schemes for predicting stroke results from the national registry of atrial fibrillation. JAMA 2001;282:2864-2870
16. Rivas N, Ferreira-González I, Tornos P, et al. Enoxaparin as bridging anticoagulant treatment in cardiac surgery. Heart 2008;94:205-210 (Pubitemid 351211731)
17. Platelet receptor inhibition in ischemic syndrome management in patients limited by unstable signs and symptoms (PRISM-PLUS) Study investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488-1497
18. Cutlip DE, Windecker S, Mehran R, et al. On behalf of the Academic Research Consortium. Clinical end points in coronary stent trials. A case for standardized definitions. Circulation 2007;115:2344-2351
19. Connolly S, Pogue J, Hart R, et al. ACTIVE writing Group on behalf on the ACTIVE Investigators. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbersatan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet 2006;367:1903-1912
20. Ruiz-Nodar JM, Marín F, Hurtado JA, et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation. J Am Coll Cardiol 2008;51:818-825
21. Nguyen M, Lim YL, Walton A, et al. GRACE Investigators. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Eur Heart J 2007;28:1717-1722